Remove Bipolar disorder Remove Books Remove Sleep and mental health
article thumbnail

Brief Book Reviews: July 2025

Psychiatric Times

Higgins, MD These 2 compelling memoirs delve into the complexities of schizophrenia, showcasing resilience, friendship, and the impact of mental health.

article thumbnail

Introducing the Borderline Personality Disorder Inventory

Psychiatric Times

Developed with input from international mental health professionals, the BPD-I™ is freely available for clinical use, education, and research. It serves as a quick assessment tool for clinicians, aligning with psychodynamic theory, but does not replace a full diagnostic evaluation.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Eyes, Ears, and Emotion: Techniques to Tackle Diagnosing Bipolar Disorder

Psychiatric Times

News Media Peer Exchange Case-Based Psych Perspectives Clinical Case Collective Insights Peers & Perspectives Slideshows Videos Conferences Conference Coverage Conference Listing Publication Psychiatric Times Job Board CME/CE Partners Editorial Resources Between the Lines Expert Perspectives Clinical Consult Clinical Scales Interactive Tools Partner (..)

article thumbnail

What Is a Sleep Disorder? A Harmful Dysfunction Analysis

Psychiatric Times

A Harmful Dysfunction Analysis Author(s): Jean-Arthur Micoulaud-Franchi, MD, PhD , Christophe Gauld, MD, PhD +2 More Key Takeaways Sleep medicine lacks a structured definition for disorders, complicating diagnosis and classification compared to psychiatry's DSM framework.

article thumbnail

Exploring NMDA Antagonists for MDD

Psychiatric Times

Leah Kuntz October 7th 2021 Blue Light Blockers: A Behavior Therapy for Mania Chris Aiken, MD Kellie Newsome, PMH-NP July 7th 2025 Transformation 2.0: The GLP-1 RAs as Psychiatric Medications?

article thumbnail

COMP360 Psilocybin for Treatment-Resistant Depression: Positive Phase 3 Efficacy Data

Psychiatric Times

The COMP005 trial is the first phase 3 study of synthetic psilocybin, marking a milestone in psychedelic research for mental health. No unexpected safety issues or imbalance in suicidal ideation were observed between treatment and placebo groups.

article thumbnail

Gerald Maguire, MD, Provides Tips for Differentiating Bipolar Depression From MDD

Psychiatric Times

Similarly, because patients with bipolar disorder often self-medicate, looking for a family history of substance abuse can be helpful. “iI's Family histories can also support the differential diagnosis , he said. For instance, if there is a family history of suicides, that may be a clue, he explained.